Risk of recurrence after cessation of dichoptic, binocular treatment of amblyopia.


Journal

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
ISSN: 1528-3933
Titre abrégé: J AAPOS
Pays: United States
ID NLM: 9710011

Informations de publication

Date de publication:
10 2023
Historique:
received: 20 03 2023
revised: 09 06 2023
accepted: 16 06 2023
pmc-release: 01 10 2024
medline: 23 10 2023
pubmed: 25 8 2023
entrez: 24 8 2023
Statut: ppublish

Résumé

Contrast-rebalanced dichoptic games and videos have been shown to be an effective treatment for childhood amblyopia. Whether the visual acuity gains achieved with these binocular treatments are long-lasting has not been determined. In this prospective cohort study of 100 consecutive amblyopic children who improved by ≥0.2 logMAR or obtained ≤0.2 logMAR amblyopic eye visual acuity during a binocular treatment clinical trial, risk of recurrence was 24% (95% CI, 16%-35%) at up to 3 years' follow-up according to Kaplan-Meier survival analysis, which accounts for censored, truncated, and missing data. Risk of recurrence was similar among children who required additional treatment for residual amblyopia after 4-8 weeks of dichoptic treatment (n = 62 [19%]; 95% CI, 10%-34%) and those who did not (n = 38 [32%]; 95% CI, 18%-52%; P = 0.12). There was no association between recurrence and age, visual acuity at the end of binocular treatment, stereoacuity, or ocular alignment. In a secondary analysis to compare rates of recurrence with published data, risk of recurrence in the subset of children who had no additional treatment for residual amblyopia (28%) was similar to the reported recurrence after cessation of successful patching and atropine (24%) at 12 months. Children with successful binocular treatment of amblyopia require monitoring for recurrence of amblyopia.

Identifiants

pubmed: 37619861
pii: S1091-8531(23)00175-1
doi: 10.1016/j.jaapos.2023.06.009
pmc: PMC10592044
mid: NIHMS1926660
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT04086524', 'NCT03288948', 'NCT02365090', 'NCT03825107']

Types de publication

Case Reports Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

298-300

Subventions

Organisme : NEI NIH HHS
ID : R01 EY022313
Pays : United States

Informations de copyright

Copyright © 2023 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.

Références

JAMA Ophthalmol. 2015 Apr;133(4):479-80
pubmed: 25611129
J AAPOS. 2019 Jun;23(3):160.e1-160.e5
pubmed: 31103562
Ophthalmology. 2022 Jan;129(1):77-85
pubmed: 34534556
Optom Vis Sci. 2022 Mar 1;99(3):213-227
pubmed: 35086119
Prog Retin Eye Res. 2013 Mar;33:67-84
pubmed: 23201436
Sci Rep. 2022 Mar 9;12(1):4157
pubmed: 35264692
Optom Vis Sci. 2020 May;97(5):316-323
pubmed: 32413002
J AAPOS. 2004 Oct;8(5):420-8
pubmed: 15492733
BMJ Open Ophthalmol. 2022 May;7(1):
pubmed: 36161844

Auteurs

Reed M Jost (RM)

Retina Foundation of the Southwest, Dallas, Texas. Electronic address: reedjost@retinafoundation.org.

Krista R Kelly (KR)

Retina Foundation of the Southwest.

Eileen E Birch (EE)

Retina Foundation of the Southwest, Dallas, Texas; Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH